Spedox-6: Clinical Trials

1 trial of Spedox-6, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Spedox-6: new trials by email Literature Review of Spedox-6 trials Research Report on Spedox-6

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies
Spedox-6, Pegfilgrastim, Filgrastim - Soft-tissue Sarcoma, Triple Negative Breast Cancer
Phase 1 / Phase 2RecruitingUniversity of California, Irvine672025-04-302026-07-17

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Ovarian Neoplasms (1)  ·  Sarcoma (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

University of California, Irvine (1)

Countries

United States (1)

Top investigators

Warren Chow, MD (1)